Phico Therapeutics Limited
Company profile · Milton Keynes
DissolvedUnited KingdomIncorporated 2000
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2022-08-31
IXBRL · 135 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2022-08-31
IXBRL · 135 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2021-09-01 to 2022-08-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 76
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0015_04062313_20220831
- Source archive
- Accounts_Monthly_Data-May2023.zip
Accounts to 2021-08-31
IXBRL · 136 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2021-08-31
IXBRL · 136 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2020-09-01 to 2021-08-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 76
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0106_04062313_20210831
- Source archive
- Accounts_Monthly_Data-May2022.zip
Accounts to 2020-08-31
IXBRL · 147 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2020-08-31
IXBRL · 147 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2019-09-01 to 2020-08-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 86
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0090_04062313_20200831
- Source archive
- Accounts_Monthly_Data-May2021.zip
Accounts to 2019-08-31
IXBRL · 139 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2019-08-31
IXBRL · 139 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2018-09-01 to 2019-08-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 78
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0076_04062313_20190831
- Source archive
- Accounts_Monthly_Data-March2020.zip
Accounts to 2018-08-31
IXBRL · 137 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2018-08-31
IXBRL · 137 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2017-09-01 to 2018-08-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 78
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0063_04062313_20180831
- Source archive
- Accounts_Monthly_Data-February2019.zip
Accounts to 2016-08-31
IXBRL · 137 source facts · 19 selected values
Not assessedlegacy record
Accounts to 2016-08-31
IXBRL · 137 source facts · 19 selected values
Not assessed
legacy record
- Reporting period
- 2015-09-01 to 2016-08-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 81
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0042_04062313_20160831
- Source archive
- Accounts_Monthly_Data-May2017.zip
Accounts to 2015-08-31
IXBRL · 86 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2015-08-31
IXBRL · 86 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2014-09-01 to 2015-08-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 34
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0030_04062313_20150831
- Source archive
- Accounts_Monthly_Data-May2016.zip
Accounts to 2014-08-31
IXBRL · 88 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2014-08-31
IXBRL · 88 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2013-09-01 to 2014-08-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 36
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0018_04062313_20140831
- Source archive
- Accounts_Monthly_Data-May2015.zip
Accounts to 2013-08-31
IXBRL · 85 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2013-08-31
IXBRL · 85 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2012-09-01 to 2013-08-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 34
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_9999_04062313_20130831
- Source archive
- Accounts_Monthly_Data-February2014.zip
Accounts to 2012-08-31
IXBRL · 87 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2012-08-31
IXBRL · 87 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2011-09-01 to 2012-08-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 36
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_9986_04062313_20120831
- Source archive
- Accounts_Monthly_Data-January2013.zip
Accounts to 2008-08-31
XBRL · 50 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2008-08-31
XBRL · 50 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- — to —
- Extraction status
- Legacy / not assessed
- Numeric facts
- 34
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-ae-2008-04-06.xsd
- Currency
- GBP
- Source identifier
- Prod224_8999_04062313_20080831
- Source archive
- Accounts_Monthly_Data-JanuaryToDecember2009.zip
Registered details
04062313- Status
- Dissolved
- Type
- Unknown
- Incorporated
- 2000-08-30
- Dissolved
- 2026-08-18
- Jurisdiction
- —
- Registered office
- 1, RADIAN COURT, MILTON KEYNES, MK5 8PJ
Classification
1 SIC codes23108
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
7 matched grantsDevelopment of Manufacturing Process of engineered - Phage for IV administration in P.aeruginosa Infections 104205Lead
Innovate UK · Feasibility Studies · 2020-06-01 – 2020-11-30
£177,039
awarded
Development of Manufacturing Process of Engineered-Phage for IV administration in P.aeruginosa infectionsISCF · Collaborative R&D · 2018-03-01 – 2021-12-31 · with 2 other participants£1,390,139whole project
Development of Manufacturing Process of Engineered-Phage for IV administration in P.aeruginosa infections
ISCF · Collaborative R&D · 2018-03-01 – 2021-12-31 · with 2 other participants
£1,390,139
whole project
Development of Manufacturing Process of Engineered-Phage for IV administration in P.aeruginosa infectionsLeadInnovate UK · Collaborative R&D · 2018-03-01 – 2021-12-31 · with 2 other participants£1,385,190awarded
Development of Manufacturing Process of Engineered-Phage for IV administration in P.aeruginosa infectionsLead
Innovate UK · Collaborative R&D · 2018-03-01 – 2021-12-31 · with 2 other participants
£1,385,190
awarded
Phico Therapeutics Limitedlead£1,385,190
Development of Manufacturing Process of Engineered-Phage for IV administration in P.aeruginosa infectionsLeadISCF · Collaborative R&D · 2018-03-01 – 2021-12-31 · with 2 other participants£1,390,139whole project
Development of Manufacturing Process of Engineered-Phage for IV administration in P.aeruginosa infectionsLead
ISCF · Collaborative R&D · 2018-03-01 – 2021-12-31 · with 2 other participants
£1,390,139
whole project
Development of a novel antibacterial agent against Pseudomonas aeruginosaLead
Innovate UK · Collaborative R&D · 2014-09-01 – 2016-12-31
£965,008
awarded
Phico Therapeutics Limited: Analysis of the product opportunities for a novel anti-bacterial platform technologyLead
Innovate UK · GRD Proof of Market · 2012-12-01 – 2013-03-31
£20,000
awarded
Phase I Clinical Trial of novel antibacterial agent, PT3.9, against Pseudomonas aeruginosaLead
Innovate UK · Feasibility Studies